The Ozempic and Wegovy mistake sending thousands to poison control

The explosive growth in semaglutide (Ozempic and Wegovy) We use after its FDA approval for chronic weight management in 2021 was accompanied by another trend that drew researchers’ attention: a dramatic increase in calls to poison control centers across the United States.

Click here to view the original article.